Beauty Farm Medical & Health Industry, Inc. stock analysis
Want to see HK:2373 full AI Analyst Report?
Beauty Farm Medical & Health Industry, Inc. (2373) Stock Price & Analysis
2373 Stock Chart & Stats
- Day’s Range
- HKD 18.32 - HKD 19.19
- 52-Week Range
- HKD 15.60 - HKD 30.30
- Previous Close
- HKD 19.00
- Volume
- N/A
- Average Volume (3M)
- 168.81K
- Market Cap
- HKD 4.77B
- Enterprise Value
- HKD 2.92B
- Total Cash (Recent Filing)
- HKD 2.41B
- Total Debt (Recent Filing)
- HKD 1.32B
- Price to Earnings (P/E)
- 10.1
- Beta
- 0.63
- Next Earnings
- Mar 31, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Aug 19, 2026
- Dividend Yield
- 3.78%
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth
Strong multi-year revenue expansion, particularly the 2025 step-up, indicates improving demand and business scale. If maintained, this growth can support operating leverage, strengthen market position, and provide a larger base from which profitability and cash generation can compound.
Improving Profitability
The improvement in net and gross margins shows that recent growth has translated into better profitability rather than merely higher sales. Higher underlying margins can improve internal funding capacity, support reinvestment, and provide greater resilience against operating cost pressure.
Positive Cash Generation
Rising operating and free cash flow demonstrate that the company is converting reported business activity into cash. This supports ongoing investment, debt servicing, and shareholder returns, while reducing reliance on external financing to sustain operations and growth.
Bears Say
Higher Financial Leverage
The sharp increase in debt-to-equity materially reduces balance-sheet flexibility compared with prior years. Higher leverage can increase financing demands and make the company more sensitive to earnings or cash-flow setbacks, potentially limiting investment and capital-allocation options.
Cash-Flow Quality Uncertainty
Although cash generation remains positive, the reported coverage indicators and negative free-cash-flow growth create uncertainty about consistency and cash-flow quality. This makes it harder to assess sustainable funding capacity and reduces confidence in the durability of recent cash conversion.
Uneven Earnings Stability
Recent profitability gains are encouraging, but the history of revenue contraction and notable EBITDA-margin volatility shows that earnings power has not been fully consistent. Such variability can complicate forecasting and make future margin performance more dependent on operating conditions.
Beauty Farm Medical & Health Industry, Inc. News
2373 FAQ
What was Beauty Farm Medical & Health Industry, Inc.’s price range in the past 12 months?
What is Beauty Farm Medical & Health Industry, Inc.’s market cap?
When is Beauty Farm Medical & Health Industry, Inc.’s upcoming earnings report date?
How were Beauty Farm Medical & Health Industry, Inc.’s earnings last quarter?
Is Beauty Farm Medical & Health Industry, Inc. overvalued?
Does Beauty Farm Medical & Health Industry, Inc. pay dividends?
What is Beauty Farm Medical & Health Industry, Inc.’s EPS estimate?
How many shares outstanding does Beauty Farm Medical & Health Industry, Inc. have?
What happened to Beauty Farm Medical & Health Industry, Inc.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Beauty Farm Medical & Health Industry, Inc.?
What is the TipRanks Smart Score and how is it calculated?
Beauty Farm Medical & Health Industry, Inc. Stock Smart Score
Company Description
Beauty Farm Medical & Health Industry, Inc.
Beauty Farm Medical and Health Industry Inc., established in 1993 and based in Shanghai, People's Republic of China, delivers comprehensive beauty and health management services across China. Its diverse offerings encompass traditional beauty treatments; advanced aesthetic medical services, including non-surgical options like energy-based therapies and injections, as well as surgical procedures; and specialized subhealth assessment and intervention programs. As of June 30, 2022, the company operated a network of 352 stores under its BeautyFarm, Palaispa, Neology, and CellCare brands, with 177 being directly owned and 175 franchised.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Songyong Lian
- Employees
- 6,975
- Website
- www.beautyfarm.com.cn
- Address
- CN
Beauty Farm Medical & Health Industry, Inc. (2373) Earnings & Revenues
2373 Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 12 | 5 | 5 |
| Technical Analysis | 2 | 5 | 3 |
| Moving Averages | 10 | 0 | 2 |










